Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)Inge Ubink, Inne H.M. Borel Rinkes, Sjoerd G. Elias et al.|BMC Cancer|2017Cited by 14